About Akebia Therapeutics

akebia.com

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

Revenue : 200M-1000M Industry : Biotechnology Location : United States Employees : 200-500

SaaS Adoption

SaaS Adoption indicates the level of adoption by this company of software as a service services.

Cloud Adoption

Cloud Adoption indicates the level of adoption by this company of cloud services.

IT Footprint

IT Footprint gives a relative indication of how much IT services this company consumes.

IT Spend

IT Spend shows roughly how much this client spends on IT per year in USD.

Enlyft tracks the use of over 15,000 technologies and has proprietary data on over 18 million companies worldwide.

Know the products your prospects use

Enlyft provides you with access to our real-time data platform where you can access insights into a company’s tech stack, firmographic data, and more.

Vendor Usage

Akebia Therapeutics uses 5 different technologies from 45 different vendors. They have above average use of several technologies including Onit, SimpleLegal and Veeva Systems.

Product Categories

Akebia Therapeutics uses products from 37 different product categories. They are particularly heavy users of products in Business Intelligence, Office Productivity, and Customer Relationship Management (CRM).

Recently Detected Technologies

Enlyft tracks the use of over 15,000 technologies and has proprietary data on over 18 million companies worldwide.

Technology Category Vendor Usage
OpenX Ad Servers OpenX
Workiva Enterprise GRC Workiva
Veeva Systems Customer Relationship Management (CRM) Veeva Systems
Veeva Vault Enterprise Content Management Veeva Systems
Legal-X Law Practice Management Bottomline Technologies (de), Inc.

Are you interested in knowing other companies with similar tech stacks?

Reveal what vendors your prospects are using

Enlyft Sales Insights gives you instant access to the tech stack and firmographics of millions of companies worldwide.
Logos provided by Clearbit

© Enlyft | All rights reserved.